Diltiazem HCl in 0 — Class II drug recall D-0355-2023
Terminated recall by Nephron Sterile Compounding Center LLC, reported 2023-03-08, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0355-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Nephron Sterile Compounding Center LLC, West Columbia, SC, United States |
| Recall initiated | 2023-02-22 |
| Classified | 2023-02-27 |
| Reported by FDA | 2023-03-08 |
| Terminated | 2024-09-24 |
| Distributed | Nationwide (US) |
| Quantity | 4,743 bottles |
| Reason classes | sterility |
| NDC | 69374-0997-15 |
| Lot numbers | DS2053 |
| Expiration dates | 2023-02-27 |
Product
Diltiazem HCl in 0.7% Sodium Chloride Injection, 125 mg/125 mL (1 mg/mL), 125 mL Single-Dose Container bottle, packaged in 15 x 1 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-997-15.
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0355-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.